Biology and Neuropathology of Prion Diseases

Handbook of Clinical Neurology

Volumn 89, Issue , 2008, Pages 779-797

  Ironside, James W ^a   Head, Mark W ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BRAIN; CLASSIFICATION; GENETICS; HUMAN; METABOLISM; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVE; PRION; PRION DISEASE; REVIEW;

ANIMALS; BRAIN; HUMANS; MUTATION; PERIPHERAL NERVES; PRION DISEASES; PRIONS;

EID: 64449085391     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)01268-7     Document Type: Review

References (115)

1. Aguzzi A., and Polymenidou M. Mammalian prion biology: one century of evolving concepts. Cell 116 (2004) 313-327
2. Almer G., Hainfellner J.A., Brucke T., et al. Fatal familial insomnia: a new Austrian family. Brain 122 (1999) 5-16
3. Alperovitch A., Zerr I., Pocchiari M., et al. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 353 (1999) 1673-1674
4. Bell J.E., Gentleman S.M., Ironside J.W., et al. Prion protein immunocytochemistry-UK five centre consensus report. Neuropathol Appl Neurobiol 23 (1997) 26-35
5. Bessen R.A., and Marsh R.F. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68 (1994) 7859-7868
6. Bishop M.T., Hart P., Aitchison L., et al. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 5 (2006) 393-398
7. Brandel J.P., Preece M., Brown P., et al. Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet 62 (2003) 128-130
8. Brandner S., Isenmann S., Raeber A., et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379 (1996) 339-343
9. C) is required for scrapie spread within the central nervous system. Proc Natl Acad Sci U S A 93 (1996) 13148-13151
10. Brown D.R. Prion and prejudice: normal protein and the synapse. Trends Neurosci 24 (2001) 85-90
11. Brown P., Gibbs Jr. C.J., Rodgers-Johnson P., et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35 (1994) 513-529
12. Brown P., Brandel J.P., Preece M., et al. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 67 (2006) 389-393
13. Bruce M.E. TSE strain variation. In: Weissman C., Aguzzi A., Dormont D., and Hunter N. (Eds). Prions for physicians Vol. 66 (2003), British Medical Bulletin, Oxford 99-108
14. Bruce E., Will R.G., Ironside J.W., et al. Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature 389 (1997) 498-501
15. Bruce M.E., McConnell I., Will R.G., et al. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 358 (2001) 208-209
16. Budka H. Neuropathology of prion disease. In: Weissman C., Aguzzi A., Dormont D., and Hunter N. (Eds). Prions for physicians Vol. 66 (2003), British Medical Bulletin, Oxford 213-239
17. Budka H., Aguzzi A., Brown P., et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies. Brain Pathol 4 (1995) 459-466
18. Bueler H., Aguzzi A., Sailer A., et al. Mice devoid of PrP are resistant to scrapie. Cell 73 (1993) 1339-1347
19. Bugiani O., Giaccone G., Verga L., et al. Beta APP participates in PrP-amyloid plaques of Gerstmann-Straussler-Scheinker disease, Indiana kindred. J Neuropathol Exp Neurol 52 (1993) 64-70
20. Castilla J., Saa P., and Soto C. Detection of prions in blood. Nature Med 11 (2005) 982-985
21. Castilla J., Saa P., Hetz C., et al. In vitro generation of infectious scrapie prions. Cell 121 (2005) 195-206
22. Caughey B. Prion protein conversions: insight into mechanisms, TSE transmission barriers and strains. In: Weissman C., Aguzzi A., Dormont D., and Hunter N. (Eds). Prions for physicians Vol. 66 (2003), British Medical Bulletin, Oxford 109-120
23. Caughey B., and Baron G.S. Prions and their partners in crime. Nature 443 (2006) 803-810
24. Cervenakova L., Goldfarb L.G., Garruto R., et al. Phenotype-genotype studies in kuru: Implications for new variant Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A 95 (1998) 13239-13241
25. Collie D.A., Summers D.M., Sellar R.J., et al. Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. Am J Neuroradiol 24 (2003) 1560-1569
26. Collinge J., Whittington M.A., Sidle K.C.L., et al. Prion protein is necessary for normal synaptic function. Nature 370 (1994) 295-297
27. Collinge J., Sidle K.C.L., Meads J., et al. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383 (1996) 685-690
28. Collinge J., Whitfield J., McKintosh E., et al. Kuru in the 21st century - an acquired human prion disease with very long incubation periods. Lancet 367 (2006) 2068-2074
29. Deleault N.R., Lucassen R.W., and Supattapone S. RNA molecules stimulate prion protein conversion. Nature 425 (2003) 717-720
30. Deslys J., Jaegly A., Huillard d'Aignaux J., et al. Genotype at codon 129 and susceptibility to Creutzfeldt-Jakob disease. Lancet 351 (1998) 1251
31. Duffy P., Wolf J., Collins G., et al. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 290 (1974) 692-693
32. Forloni G., Angeretti N., Chiesa R., et al. Neurotoxicity of a prion protein fragment. Nature 362 (1993) 543-546
33. Gajdusek D.C., and Zigas V. Degenerative disease of the central nervous system in New Guinea. The endemic occurrence of "kuru" in the native population. N Engl J Med 257 (1957) 974-978
34. Gambetti P., Kong Q., Zou W., et al. Sporadic and familial CJD: classification and characterisation. In: Weissman C., Aguzzi A., Dormont D., and Hunter N. (Eds). Prions for physicians Vol. 66 (2003), British Medical Bulletin, Oxford 213-239
35. Ghetti B., Tagliavini F., Takao M., et al. Hereditary prion protein amyloidoses. Clin Lab Med 23 (2003) 65-85
36. Giese A., and Kretzschmar H.A. Prion-induced neuronal damage-the mechanisms of neuronal destruction in the subacute spongiform encephalopathies. Curr Top Microbiol Immunol 253 (2001) 203-217
37. Glatzel M., Abela E., Maissen M., et al. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 349 (2003) 1812-1820
38. Goldfarb L.G., Cervenakova L., and Gajdusek D.C. Genetic studies in relation to kuru: an overview. Curr Mol Med 4 (2004) 375-384
39. Govaerts C. Structural studies of prion proteins. In: Crotty D., and Schaefer S. (Eds). Prion Biology and Diseases. second edition (2004), Cold Spring Harbor Laboratory Press, New York 243-282
40. Guentchev M., Hainfellner J.A., Trabattoni G.R., et al. Distribution of parvalbumin-immunoreactive neurons in brain correlates with hippocampal and temporal cortical pathology in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 56 (1997) 1119-1124
41. Guentchev M., Groschup M.H., Kordek R., et al. Severe, early and selective loss of a subpopulation of gabaergic inhibitory neurons in experimental transmissible spongiform encephalopathies. Brain Pathol 8 (1998) 615-623
42. Guentchev M., Voigtlander T., Haberler C., et al. Evidence for oxidative stress in experimental prion disease. Neurobiol Dis 7 (2000) 270-273
43. Hainfellner J., Brantner-Inhaler S., Cervenakova L., et al. The original Gerstmann-Straussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol 5 (1995) 201-213
44. Hainfellner J.A., Liberski P.P., Guiroy D.C., et al. Pathology and immunocytochemistry of a kuru brain. Brain Pathol 7 (1997) 547-553
45. Harris D.A. Cell biology of prions. In: Crotty D., and Schaefer S. (Eds). Prion Biology and Diseases. second edition (2004), Cold Spring Harbor Laboratory Press, New York 483-544
46. Head M.W., Tissingh G., Uitdehaag B.M., et al. Sporadic Creutzfeldt-Jakob disease in a young Dutch valine homozygote: atypical molecular phenotype. Ann Neurol 50 (2001) 258-261
47. Head M.W., Bunn T.J.R., Bishop M.T., et al. Prion protein geterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: U.K. Cases 1991-2002. Ann Neurol 55 (2004) 851-859
48. Head M.W., Ritchie D., Smith N., et al. Peripheral tissue involvement in sporadic, iatrogenic and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative and biochemical study. Am J Pathol 164 (2004) 143-153
49. Head M.W., and Ironside J.W. Sporadic Creutzfeldt-Jakob disease: further twists and turns of a convoluted protein. Brain 129 (2006) 2238-2240
50. Heath C.A., Barker R.A., Esmonde T.F.G., et al. Dura mater-associated Creutzfeldt-Jakob disease - Experience from UK surveillance. Neurol Neurosurg, Psych 77 (2006) 880-882
51. Hegde R.S., Mastrianni J.A., Scott M.R., et al. A transmembrane form of the prion protein in neurodegenerative disease. Science 279 (1998) 827-834
52. Herms J., Tings T., Gall S., et al. Evidence of presynaptic location and function of the prion protein. J Neurosci 19 (1999) 8866-8875
53. Hewitt P.E., Llewelyn C.A., Mackenzie J., et al. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological review study. Vox Sang 91 (2006) 221-230
54. Hill A.F., Butterworth R.J., Joiner S., et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353 (1999) 183-189
55. Hill A.F., Joiner S., Wadsworth J.D.F., et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126 (2003) 1333-1346
56. Hilton D.A., Fathers E., Edwards P., et al. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 352 (1998) 703-704
57. Hilton D.A., Ghani A.C., Conyers L., et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203 (2004) 733-739
58. Hsiao K., Baker H.F., Crow T.J., et al. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338 (1989) 342-345
59. Ironside J.W. Creutzfeldt-Jakob disease. Brain Pathol 6 (1996) 379-388
60. Ironside J.W., Head M.W., Bell J.E., et al. Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathology 37 (2000) 1-9
61. Ironside J.W., McCardle L., Horsburgh A., et al. Pathological diagnosis of variant Creutzfeldt-Jakob disease. APMIS 11 (2002) 79-87
62. Ironside J.W., Ritchie D.L., and Head M.W. Phenotypic variability in human prion diseases. J Neuropathol Appl Neurobiol J Neuropathol Appl Neurobiol 31 (2005) 1-15
63. Ironside J.W., Bishop M.T., Connolly K., et al. Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ 332 (2006) 1186-1188
64. Jackson G.S., Hosszu L.L.P., Power A., et al. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 283 (1999) 1935-1937
65. King A., Doey L., Rossor M., et al. Phenotypic variability in the brains of a family with a prion disease characterized by a 144-base pair insertion in the prion protein gene. Neuropathol Appl Neurobiol 29 (2003) 98-105
66. Kitamoto T., Iizuka R., and Tateishi J. An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant prp plaques. Biochem Biophys Res Commun 192 (1993) 525-531
67. Kocisko D.A., Come J.H., Priola S.A., et al. Cell-free formation of protease-resistant prion protein. Nature 370 (1994) 471-474
68. Koperek O., Kovacs G.G., Ritchie D., et al. Disease-associated prion protein in vessel walls. Am J Pathol 161 (2002) 1979-1984
69. Kovacs G.G., Head M.W., Hegyi I., et al. Immunohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes. Brain Pathol 12 (2002) 1-11
70. Kovacs G.G., Trabattoni G., Hainfellner J.A., et al. Mutations of the prion protein gene phenotypic spectrum. J Neurol 249 (2002) 1567-1582
71. Kovacs G.G., Gasque P., Strobel T., et al. Complement activation in human prion disease. Neurobiol Dis 15 (2004) 21-28
72. Kovacs G.G., Preusser M., Strohschneider M., et al. Subcellular localization of disease-associated prion protein in the human brain. Am J Pathol 166 (2005) 287-294
73. Ladogana A., Puopolo M., Croes E.A., et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia and Canada. Neurology 64 (2005) 1586-1591
74. Lee H.S., Sambuughin N., Cervenakova L., et al. Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease. Am J Hum Genet 64 (1999) 1063-1070
75. Legname G., Baskakov I.V., Nguyen H., et al. Synthetic mammalian prions. Science 305 (2004) 673-676
76. Liberski P.P., Yanagihara R., Wells G.A., et al. Comparative ultrastructural neuropathology of naturally occurring bovine spongiform encephalopathy and experimentally induced scrapie and Creutzfeldt-Jakob Disease. J Comp Pathol 106 (1992) 361-381
77. Llewelyn C.A., Hewitt P.E., Knight R.S., et al. Possible transmission of variant Creutzfeldt-Jakob disase by blood transfusion. Lancet 363 (2004) 417-421
78. McLean C.A., Ironside J.W., Alpers M.P., et al. Comparative neuropathology of kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host. Brain Pathol 8 (1998) 428-437
79. McLennan N.F., Brennan P.M., McNeill A., et al. Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol 165 (2004) 227-235
80. Ma J., Wollmann R., and Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298 (2002) 1781-1785
81. Masters C.L., and Richardson E.P. Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain 101 (1978) 333-344
82. Mizutani T. Neuropathology of Creutzfeldt-Jakob disease in Japan. With special reference to the panencephalopathic type. Acta Pathol Jpn 31 (1981) 903-922
83. Montagna P., Gambetti P., Cortelli P., et al. Familial and sporadic fatal insomnia. Lancet Neurol 2 (2003) 167-176
84. Mouillet-Richard S., Ermonval M., Chebassier C., et al. Signal transduction through prion protein. Science 289 (2000) 1925-1928
85. Neufeld M.Y., Josiphov J., and Korczyn A.D. Demyelinating peripheral neuropathy in Creutzfeldt-Jakob disease. Muscle Nerve 15 (1992) 1234-1239
86. Nevin S., McMenemey W.H., Behrman S., et al. Subacute spongiform encephalopathy - a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy). Brain 83 (1960) 519-563
87. Parchi P., Capellari S., Chen S.G., et al. Typing prion isoforms. Nature 386 (1997) 232-234
88. Parchi P., Chen S.G., Brown P., et al. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Straussler-Scheinker disease. Proc Natl Acad Sci U S A 95 (1998) 8322-8327
89. Parchi P., Petersen R.B., Chen S.G., et al. Molecular pathology of fatal familial insomnia. Brain Pathology 8 (1998) 539-548
90. Parchi P., Giese A., Capellari S., et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46 (1999) 224-233
91. Parchi P., Zou W., Wang W., et al. Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A 97 (2000) 10168-10172
92. Peden A.H., Head M.W., Ritchie D.L., et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364 (2004) 477-479
93. Sc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol 168 (2006) 927-935
94. Piccardo P., Dloughy S.R., Lievens P.M.J., et al. Phenotypic variability of Gerstmann-Straussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol 57 (1998) 979-988
95. Post K., Pitschke M., Schafer O., et al. Rapid acquisition of ß-sheet structure in the prion protein prior to multimer formation. Biol Chem 379 (1998) 1307-1317
96. Prusiner S.B. An introduction to prion biology and diseases. In: Crotty D., and Schaefer S. (Eds). Prion Biology and Diseases. second edition (2004), Cold Spring Harbor Laboratory Press, New York 1-87
97. Prusiner S.B. Development of the prion concept. In: Crotty D., and Schaefer S. (Eds). Prion Biology and Diseases. second edition (2004), Cold Spring Harbor Laboratory Press, New York 89-141
98. Puoti G., Rossi G., Giaccone G., et al. Polymorphism at codon 129 of PRNP affects the phenotypic expression of Creutzfeldt-Jakob disease linked to E200K mutation. Ann Neurol 48 (2000) 269-270
99. Rieger R., Edenhofer F., Lasmezas C.I., et al. The human 37-kda laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nature Med 3 (1997) 1383-1388
100. Ritchie D.L., Head M.W., and Ironside J.W. Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting. Neuropathol Appl Neurobiol 30 (2004) 360-368
101. Saborio G.P., Permanne B., and Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411 (2001) 810-813
102. Santuccione A., Sytnyk V., Leshchyns'ka I., et al. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 169 (2005) 341-354
103. Satoh K., Muramoto T., Tanaka T., et al. Association of an 11-12 kda protease-resistant prion protein fragment with subtypes of dura graft-associated Creutzfeldt-Jakob disease and other prion diseases. J Gen Virol 84 (2003) 2885-2893
104. Scott M. Transgenetic investigations of the species barrier and prion strains. In: Crotty D., and Schaefer S. (Eds). Prion Biology and Diseases. second edition (2004), Cold Spring Harbor Laboratory Press, New York 435-482
105. Shimizu S., Hoshi T., Homma M., et al. Creutzfeldt-Jakob disease with florid-type plaques after cadaveric dura mater grafting. Arch Neurol 56 (1999) 357-363
106. Si K., Lindquist S., and Kandel E.R. A neuronal isoform of the Aplysia CFEB has prion-like properties. Cell 115 (2003) 879-891
107. Swerdlow A.J., Higgins C.D., Adlard P., et al. Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone. Neurology 61 (2003) 783-791
108. Tagliavini F., Forloni G., D'Ursi P., et al. Studies on peptide fragments of prion proteins. Adv Protein Chem 57 (2001) 171-201
109. Telling G.C., Parchi P., DeArmond S.J., et al. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274 (1996) 2079-2082
110. Tsuchiya K., Yagishita S., Ikeda K., et al. Coexistence of CJD and Alzheimer's disease: an autopsy case showing typical clinical features of CJD. Neuropathology 24 (2004) 46-55
111. Vital C., Gray F., Vital A., et al. Prion encephalopathy with insertion of octapeptide repeats: the number of repeats determines the type of cerebellar deposits. Neuropathol Appl Neurobiol 24 (1998) 125-130
112. Ward H.J., Everington D., Croes E.A., et al. Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. Neurology 59 (2002) 543-548
113. Wickner R.B., Edskes H.K., Ross E.D., et al. Prions of yeast are genes made of protein: amyloids and enzymes. Cold Spring Harb Symp Quant Biol 69 (2004) 489-496
114. Will R.G., Ironside J.W., Zeidler M., et al. A new variant Creutzfeldt-Jakob disease in the UK. Lancet 347 (1996) 921-925
115. Wong B., Liu T., Ruliang L., et al. Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein. J Neurochem 76 (2001) 565-572